TRU-015

DB05580InvestigationalSmall molecule

Investigated for use/treatment in lymphoma (unspecified) and rheumatoid arthritis.

Mechanism: Pharmacologically active on B-lymphocyte antigen CD20
Curator reviewed
Primary indication: Investigated for use/treatment in lymphoma (unspecified) and rheumatoid arthritis.Curator reviewed
Code names: TRU-015

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with TRU-015, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.